|
|
Welcome to InsulinDevice.com
At Novo Nordisk, we've spent over 80 years trying to make the lives of people with diabetes easier. This site is dedicated to our range of insulin delivery systems — the largest in the world. Each of our devices was developed with our customers in mind and provides accurate dosing in an easy-to-use format.
We hope you'll find the information provided here to be helpful. To find out more about any of our insulin delivery systems, simply use the navigation buttons to the left or click on the name of the device below you would like to see.
Levemir Important Safety Information: People who are allergic to insulin or the other ingredients in Levemir should not take Levemir. Insulins, including Levemir, can cause low blood sugar. This is the most common side effect. The timing of when it occurs may not be the same for different insulin products. You must test your blood sugar levels while using an insulin, such as Levemir. Your doctor will tell you how often you should test your blood sugar level, and what to do if it is high or low. Do not change the insulin you are using without talking to your doctor. Doses of oral anti-diabetic medicines may also need to change. Your insulin needs may change due to a number of factors, such as illness, stress, medicines, or changes in diet or exercise routines. Levemir should not be diluted or mixed with any other insulin or solution. Before starting Levemir, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, are breast-feeding or planning to breast-feed, or take any other medicines. Do not start any new medicines until you know how they may affect your insulin dose. When you take Levemir, you may notice some side effects common to insulin. These include high blood sugar, reaction at the injection site (like redness, swelling, and itching), or allergic reactions. Other rare but serious side effects could occur. Talk to your doctor right away if you notice any side effects.
Indications and Usage: Levemir (insulin detemir [rDNA origin] injection) is used to treat patients with diabetes for the control of high blood sugar. It’s used once or twice a day to lower blood sugar. Click here for full Prescribing Information
NovoLog Mix 70/30 Important Safety Information: You should know that NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is different from other insulin mixtures because it works fast. So it’s important to take your dose within 15 minutes of a meal. Also, check your blood glucose regularly. Do not use NovoLog Mix 70/30 if your blood glucose is too low or if you are allergic to this medication. Low blood glucose is the most common side effect. If you have been taking another type of insulin, the time at which low blood glucose could occur may be different. Any change in insulin should be made cautiously and only under medical supervision. Indications and Usage: NovoLog Mix 70/30 is for use in patients with diabetes to control high blood glucose. Click here for full Prescribing Information
NovoLog Important Safety Information: NovoLog® (insulin aspart [rDNA origin] injection) is different from regular human insulin. It works faster and will not work as long as regular human insulin. A NovoLog® injection should immediately be followed by a meal. Because of the short duration of action of NovoLog®, patients also require a longer-acting insulin to maintain adequate glucose control. Low blood glucose is the most common side effect of insulin therapy, including NovoLog®. Any change in insulin should be made cautiously and only under medical supervision. Indications and Usage: NovoLog® is for use in patients with diabetes to control high blood glucose. Click here for full Prescribing Information
Any change in insulin should be made cautiously and only under medical supervision.
Levemir, InnoLet, FlexPen, NovoPen, NovoFine, PenFill, NovoLog, and Novolin are registered trademarks of Novo Nordisk A/S. — ©2005 Novo Nordisk Inc.
|